# ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
Canonical URL: https://biopharmsignal.com/news/PROK/prokidney-presents-full-results-from-the-phase-2-regen-007-trial-of-rilparencel-at-the-american-society-of-nephrology-kidney-week-2025
Ticker: PROK
Company: ProKidney
Source: ProKidney
Published: 2025-11-06 16:00 EST
Original Source URL: https://investors.prokidney.com
## Summary

In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically significant and clinically meaningful slowing of CKD progression Bilateral kidney injection with rilparencel resulted in a 4.6 mL/min/1.73m 2 (78%) improvement in the annual

## Article Body
In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically significant and clinically meaningful slowing of CKD progression Bilateral kidney injection with rilparencel resulted in a 4.6 mL/min/1.73m 2 (78%) improvement in the annual
## Recent Company News
- 2026-06-02 12:00 EST — [ProKidney Appoints Kenneth Locke as Chief Technical Officer](https://biopharmsignal.com/news/PROK/prokidney-appoints-kenneth-locke-as-chief-technical-officer) — Source: ProKidney
- 2026-05-15 15:45 EST — [ProKidney Reports First Quarter 2026 Financial Results and Business Highlights](https://biopharmsignal.com/news/PROK/prokidney-reports-first-quarter-2026-financial-results-and-business-highlights) — Source: ProKidney
- 2026-03-25 20:01 EST — [ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer](https://biopharmsignal.com/news/PROK/prokidney-expands-senior-leadership-team-with-appointment-of-greg-madison-as-chief-commercial-officer) — Source: ProKidney
- 2026-03-18 20:00 EST — [ProKidney Reports Full Year 2025 Financial Results and Business Highlights](https://biopharmsignal.com/news/PROK/prokidney-reports-full-year-2025-financial-results-and-business-highlights) — Source: ProKidney
- 2026-01-06 12:30 EST — [ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference](https://biopharmsignal.com/news/PROK/prokidney-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference) — Source: ProKidney
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)